GlassScriptPhysician profile
Ameen Barghi
NPI 1679102909
$8,674.45
in general payments reported to CMS, 2019-2025
9 companies · $5,859 in 2025
The $5,859 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.66 · 2022: $63.12 · 2023: $1,928 · 2024: $748 · 2025: $5,859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,769 · Consulting Fee: $2,839 · Food and Beverage: $1,926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,769.32 |
| Consulting Fee | $2,839.32 |
| Food and Beverage | $1,926.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vb Spine LLC | $4,468.88 | 2025 | Everest Spinal System |
| Stryker Corporation | $2,097.24 | 2022-2025 | Everest Spinal System, Cascadia Interbody System, Inspace |
| Globus Medical, INC. | $1,144.07 | 2024-2025 | Excelsius Gps, Quartex, Reline |
| Medtronic, INC. | $265.29 | 2021-2025 | |
| Cerapedics INC. | $252.05 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Kuros Biosciences USA, INC | $188.34 | 2025 | Magnetos |
| Nuvasive Specialized Orthopedics, INC. | $146.85 | 2023 | Precice Intramedullary Limb Lengthening System |
| Depuy Synthes Sales INC. | $58.18 | 2025 | Vivigen Mis Delivery System |
| Piedmont Plus Innovation | $53.55 | 2023-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ameen Barghi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.